SFFS
Stonehage Fleming Financial Services’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.7K | Sell |
236
-1,421
| -86% | -$576K | ﹤0.01% | 161 |
|
|
2025
Q1 | $825K | Sell |
1,657
-170,412
| -99% | -$84.8M | 0.03% | 61 |
|
|
2024
Q4 | $89.5M | Sell |
172,069
-32,881
| -16% | -$17.1M | 2.51% | 18 |
|
|
2024
Q3 | $127M | Sell |
204,950
-1,810
| -0.9% | -$1.12M | 3.35% | 16 |
|
|
2024
Q2 | $114M | Buy |
+206,760
| New | +$114M | 3.05% | 14 |
|
|
2024
Q1 | – | Sell |
-204,754
| Closed | -$109M | – | 264 |
|
|
2023
Q4 | $109M | Buy |
204,754
+161,121
| +369% | +$85.5M | 3.18% | 15 |
|
|
2023
Q3 | $22M | Sell |
43,633
-173,758
| -80% | -$87.8M | 1.95% | 19 |
|
|
2023
Q2 | $113M | Buy |
+217,391
| New | +$113M | 4.14% | 10 |
|
|
2022
Q3 | – | Sell |
-224,004
| Closed | -$122M | – | 263 |
|
|
2022
Q2 | $122M | Buy |
224,004
+28,104
| +14% | +$15.3M | 4.86% | 6 |
|
|
2022
Q1 | $116M | Buy |
195,900
+12,731
| +7% | +$7.52M | 3.58% | 11 |
|
|
2021
Q4 | $122M | Buy |
183,169
+5,739
| +3% | +$3.83M | 3.34% | 13 |
|
|
2021
Q3 | $101M | Buy |
177,430
+18,177
| +11% | +$10.4M | 2.99% | 13 |
|
|
2021
Q2 | $80.4M | Buy |
159,253
+16,468
| +12% | +$8.31M | 2.35% | 17 |
|
|
2021
Q1 | $65.1M | Buy |
142,785
+66,928
| +88% | +$30.5M | 2.17% | 20 |
|
|
2020
Q4 | $35.3M | Buy |
75,857
+75,757
| +75,757% | +$35.3M | 1.19% | 23 |
|
|
2020
Q3 | $44K | Hold |
100
| – | – | ﹤0.01% | 149 |
|
|
2020
Q2 | $36K | Hold |
100
| – | – | ﹤0.01% | 131 |
|
|
2020
Q1 | $28K | Buy |
+100
| New | +$28K | ﹤0.01% | 157 |
|
|
2019
Q1 | – | Sell |
-4,360
| Closed | -$976K | – | 230 |
|
|
2018
Q4 | $976K | Buy |
4,360
+4,260
| +4,260% | +$954K | 0.05% | 73 |
|
|
2018
Q3 | $24K | Buy |
+100
| New | +$24K | ﹤0.01% | 216 |
|